デフォルト表紙
市場調査レポート
商品コード
1414024

自己細胞療法の世界市場レポート 2024年

Autologous Cell Therapy Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
自己細胞療法の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

自己細胞療法の市場規模は近年急速に拡大しています。2023年の85億8,000万米ドルから2024年には102億2,000万米ドルへと、CAGR19.2%で拡大します。過去数年間における成長の主要要因はいくつかあります。再生医療における進歩、代替治療の探求を促す慢性疾患の有病率の上昇、細胞生物学に対する理解の向上、個別化医療に対する患者の嗜好の高まり、治療手法の好結果につながる臨床的成功などです。

慢性疾患の急増が自己細胞療法の拡大に拍車をかけています。慢性疾患は1年以上続くため、継続的な治療が必要となります。自己細胞療法は、個人の培養・増幅された細胞をドナーに再導入することで、そのような疾患の管理・治療に有望です。国立医学図書館の2023年1月の報告書によると、米国では2050年までに50歳以上で少なくとも1つの慢性疾患を持つ人が1億4,266万人に達すると予測されています。したがって、慢性疾患の有病率の増加が自己細胞療法市場の成長を後押ししています。

2023年の自己細胞療法市場で最大の地域は北米です。アジア太平洋は予測期間中に最も急成長する地域と予想されます。自己細胞療法市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の自己細胞治療市場の促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の自己細胞治療市場規模実績と成長、2018~2023年
  • 世界の自己細胞治療市場規模と成長予測、2023~2028年、2033年

第6章 市場セグメンテーション

  • 世界の自己細胞治療市場、治療法別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 自己幹細胞療法
  • 自己細胞免疫療法
  • 世界の自己細胞治療市場、供給源別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 骨髄
  • 表皮
  • 間葉系幹細胞
  • 造血幹細胞
  • 軟骨細胞
  • その他の供給源
  • 世界の自己細胞治療市場、用途別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • がん
  • 神経変性疾患
  • 心血管疾患
  • 自己免疫疾患
  • 整形外科
  • 創傷治癒
  • その他の用途
  • 世界の自己細胞治療市場、エンドユーザー別セグメンテーション、実績と予測、2018~2023年、2023~2028年、2033年
  • 病院とクリニック
  • 外来センター
  • 学術と研究
  • その他のエンドユーザー

第7章 地域と国の分析

  • 世界の自己細胞治療市場、地域別、実績と予測、2018~2023年、2023~2028年、2033年
  • 世界の自己細胞治療市場、国別、実績と予測、2018~2023年、2023~2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 自己細胞治療市場の競合情勢
  • 自己細胞治療市場の企業プロファイル
    • Bristol-Myers Squibb Company
    • Novartis AG
    • Vericel Corporation
    • Holostem Terapie Avanzate Srl
    • Pharmicell Co. Ltd.

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の展望と潜在性分析

第35章 付録

目次
Product Code: r11534

“Autologous Cell Therapy Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on autologous cell therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for autologous cell therapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The autologous cell therapy market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Therapy: Autologous Stem Cell Therapy; Autologous Cellular Immunotherapies
  • 2) By Source: Bone Marrow; Epidermis; Mesenchymal Stem Cells; Hematopoietic Stem Cells; Chondrocytes; Other Sources
  • 3) By Application: Cancer; Neurodegenerative Disorders; Cardiovascular Disorders; Autoimmune Disorders; Orthopedics; Wound Healing; Other Applications
  • 4) By End User: Hospitals And Clinics; Ambulatory Centers; Academics And Research; Other End-Users
  • Companies Mentioned: Bristol-Myers Squibb Company; Novartis AG; Vericel Corporation; Holostem Terapie Avanzate S.r.l.; Pharmicell Co. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Autologous cell therapy stands as a method within cell therapy where an individual's cells are gathered, processed, and subsequently reintroduced into their own body to address therapeutic needs. It plays a vital role in regenerative medicine, aiming to repair, replace, or rejuvenate damaged tissues or organs.

Within autologous cell therapy, two primary types are prevalent, autologous stem cell therapy and autologous cellular immunotherapies. Autologous stem cell therapy, a specific facet of this therapy, harnesses stem cells sourced from the patient's own body for therapeutic purposes. These stem cells are derived from various sources such as bone marrow, epidermis, mesenchymal stem cells, hematopoietic stem cells, chondrocytes, among others. Their applications span across a wide spectrum of medical areas, including cancer, neurodegenerative disorders, cardiovascular issues, autoimmune conditions, orthopedics, and wound healing. This therapy finds application across multiple sectors including hospitals, clinics, ambulatory centers, academic and research institutions, and other healthcare settings, serving as a versatile approach in addressing various health challenges.

The autologous cell therapy market research report is one of a series of new reports from The Business Research Company that provides autologous cell therapy market statistics, including autologous cell therapy industry global market size, regional shares, competitors with a autologous cell therapy market share, detailed autologous cell therapy market segments, market trends and opportunities, and any further data you may need to thrive in the autologous cell therapy industry. This autologous cell therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The autologous cell therapy market size has grown rapidly in recent years. It will grow from $8.58 billion in 2023 to $10.22 billion in 2024 at a compound annual growth rate (CAGR) of 19.2%. During the historical period, growth can be primarily attributed to several factors. These include advancements within regenerative medicine, the rising prevalence of chronic diseases prompting the exploration of alternative treatments, improved comprehension of cellular biology, a growing preference among patients for personalized medicine, and significant clinical successes leading to positive outcomes in treatment methodologies.

The autologous cell therapy market size is expected to see rapid growth in the next few years. It will grow to $19.53 billion in 2028 at a compound annual growth rate (CAGR) of 17.6%. Anticipated growth in the forecast period is expected due to several key factors. These encompass the sustained expansion of regenerative medicine, the broadening scope of applications across diverse medical specialties, advancements in cell culture techniques, escalating investments and intensified research initiatives, as well as robust regulatory support and the establishment of standardized practices. Key trends projected for this period involve the development of automated manufacturing technologies to streamline processes, the integration of biomarkers into treatment strategies for enhanced efficacy, the emergence of point-of-care cell processing methods, the widening application beyond hematopoietic stem cells, and an increase in collaborative efforts and partnerships within the industry to foster innovation and progress.

The burgeoning prevalence of chronic diseases is poised to fuel the expansion of autologous cell therapy. Chronic diseases, persisting for more than a year, necessitate continual medical attention. Autologous cell therapy, leveraging an individual's cultivated and amplified cells reintroduced into the donor, holds promise in managing and treating such conditions. According to the National Library of Medicine's January 2023 report, the US is projected to witness 142.66 million people aged 50 and above with at least one chronic condition by 2050. Hence, the heightened prevalence of chronic diseases propels the growth of the autologous cell therapy market.

The escalating aging population is anticipated to drive the growth of the autologous cell therapy market. The aging population, characterized by rising median age and extended life expectancy, stands to benefit from autologous cell therapies due to their potential for tailored and personalized interventions. As projected by the ARC Centre of Excellence in Population Ageing Research, Australia's population aged 65 and above is estimated to surge from 4.31 million in 2021 to 6.66 million by 2041, an impressive 54% increase. Thus, the burgeoning aging demographic fuels the expansion of the autologous cell therapy market.

Technological advancements emerge as a prominent trend shaping the autologous cell therapy market. Market leaders are automating the process to enhance efficiency and ensure sustainability. Lonza, for instance, unveiled the Cocoon Platform in April 2022, a cutting-edge technology streamlining personalized cell and gene therapy manufacturing. This platform, driven by an automated closed system, minimizes contamination risk, upholds manufacturing sterility, substantially bolsters quality, reduces labor and material expenses, and facilitates the scalable production of autologous T-cell products.

Major players in the autologous cell therapy realm are forging strategic partnerships and collaborations to fortify their market positions. Strategic partnerships, fostering collaborative endeavors between multiple entities, aim to achieve specific business objectives. Notably, in March 2022, Novartis inked an initial agreement with Carisma Therapeutics, aiming to manufacture HER 2 targeted CAR-M cell therapy. The collaboration involves transferring Carisma Therapeutics' manufacturing process to Novartis' Cell Therapy Site in the US, scheduling clinical manufacturing to commence in 2023, focusing on treating solid tumors in initial trials.

In October 2023, Clade Therapeutics, a US-based cell therapy company, successfully acquired Gadeta B.V. for an undisclosed sum. This strategic acquisition significantly enriches Clade's repertoire by incorporating innovative gamma/delta (g/d) T-cell receptor (TCR)-based immunotherapies tailored for cancer patients into its existing portfolio. Gadeta B.V., based in the Netherlands, specializes in the development of cell therapies.

Major companies operating in the autologous cell therapy market report are Bristol-Myers Squibb Company, Novartis AG, Vericel Corporation, Holostem Terapie Avanzate S.r.l., Pharmicell Co. Ltd., Opexa Therapeutics Inc., Tego Science AB, Brainstorm Cell Therapeutics Inc., Caladrius Biosciences Inc., Lineage Cell Therapeutics Inc., Castle Creek Biosciences Inc., Gilead Sciences Inc., Johnson & Johnson, CORESTEM Inc., Dendreon Pharmaceuticals LLC, Medipost Co. Ltd., PharmaJet Inc., Bioject Medical Technologies Inc., Medical International Technology Inc., INJEX Pharma AG, Lonza Group Ltd., Corning Incorporated, Takeda Pharmaceutical Company Limited, CSL Limited, AstraZeneca plc, Moderna Inc., Sinovac Biotech Ltd., Valneva SE, Bavarian Nordic A/S, Dynavax Technologies Corporation

North America was the largest region in the autologous cell therapy market in 2023. Asia-pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the autologous cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the autologous cell therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The autologous cell therapy market includes revenues earned by providing services in relation to cell collection, cell processing, cell expansion, or its modification. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Autologous Cell Therapy Market Characteristics

3. Autologous Cell Therapy Market Trends And Strategies

4. Autologous Cell Therapy Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Autologous Cell Therapy Market Size and Growth

  • 5.1. Global Autologous Cell Therapy Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Autologous Cell Therapy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Autologous Cell Therapy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Autologous Cell Therapy Market Segmentation

  • 6.1. Global Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Autologous Stem Cell Therapy
  • Autologous Cellular Immunotherapies
  • 6.2. Global Autologous Cell Therapy Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Bone Marrow
  • Epidermis
  • Mesenchymal Stem Cells
  • Hematopoietic Stem Cells
  • Chondrocytes
  • Other Sources
  • 6.3. Global Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cancer
  • Neurodegenerative Disorders
  • Cardiovascular Disorders
  • Autoimmune Disorders
  • Orthopedics
  • Wound Healing
  • Other Applications
  • 6.4. Global Autologous Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Clinics
  • Ambulatory Centers
  • Academics And Research
  • Other End-Users

7. Autologous Cell Therapy Market Regional And Country Analysis

  • 7.1. Global Autologous Cell Therapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Autologous Cell Therapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Autologous Cell Therapy Market

  • 8.1. Asia-Pacific Autologous Cell Therapy Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Autologous Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Autologous Cell Therapy Market

  • 9.1. China Autologous Cell Therapy Market Overview
  • 9.2. China Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Autologous Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Autologous Cell Therapy Market

  • 10.1. India Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Autologous Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Autologous Cell Therapy Market

  • 11.1. Japan Autologous Cell Therapy Market Overview
  • 11.2. Japan Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Autologous Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Autologous Cell Therapy Market

  • 12.1. Australia Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Autologous Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Autologous Cell Therapy Market

  • 13.1. Indonesia Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Autologous Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Autologous Cell Therapy Market

  • 14.1. South Korea Autologous Cell Therapy Market Overview
  • 14.2. South Korea Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Autologous Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Autologous Cell Therapy Market

  • 15.1. Western Europe Autologous Cell Therapy Market Overview
  • 15.2. Western Europe Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Autologous Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Autologous Cell Therapy Market

  • 16.1. UK Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Autologous Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Autologous Cell Therapy Market

  • 17.1. Germany Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Autologous Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Autologous Cell Therapy Market

  • 18.1. France Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Autologous Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Autologous Cell Therapy Market

  • 19.1. Italy Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Autologous Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Autologous Cell Therapy Market

  • 20.1. Spain Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Autologous Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Autologous Cell Therapy Market

  • 21.1. Eastern Europe Autologous Cell Therapy Market Overview
  • 21.2. Eastern Europe Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Autologous Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Autologous Cell Therapy Market

  • 22.1. Russia Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Autologous Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Autologous Cell Therapy Market

  • 23.1. North America Autologous Cell Therapy Market Overview
  • 23.2. North America Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Autologous Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Autologous Cell Therapy Market

  • 24.1. USA Autologous Cell Therapy Market Overview
  • 24.2. USA Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Autologous Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Autologous Cell Therapy Market

  • 25.1. Canada Autologous Cell Therapy Market Overview
  • 25.2. Canada Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Autologous Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Autologous Cell Therapy Market

  • 26.1. South America Autologous Cell Therapy Market Overview
  • 26.2. South America Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Autologous Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Autologous Cell Therapy Market

  • 27.1. Brazil Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Autologous Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Autologous Cell Therapy Market

  • 28.1. Middle East Autologous Cell Therapy Market Overview
  • 28.2. Middle East Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Autologous Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Autologous Cell Therapy Market

  • 29.1. Africa Autologous Cell Therapy Market Overview
  • 29.2. Africa Autologous Cell Therapy Market, Segmentation By Therapy, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Autologous Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Autologous Cell Therapy Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Autologous Cell Therapy Market Competitive Landscape And Company Profiles

  • 30.1. Autologous Cell Therapy Market Competitive Landscape
  • 30.2. Autologous Cell Therapy Market Company Profiles
    • 30.2.1. Bristol-Myers Squibb Company
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Novartis AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Vericel Corporation
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Holostem Terapie Avanzate S.r.l.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Pharmicell Co. Ltd.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Autologous Cell Therapy Market Competitive Benchmarking

32. Global Autologous Cell Therapy Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Autologous Cell Therapy Market

34. Autologous Cell Therapy Market Future Outlook and Potential Analysis

  • 34.1 Autologous Cell Therapy Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Autologous Cell Therapy Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Autologous Cell Therapy Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer